Drug recall · February 14, 2018
Mycamine recall
Why: Labeling: Label Error on Declared Strength
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Mycamine (micafungin) for Injection 100 mg/vial Single-Dose Vial Rx only Marketed by: Astellas Pharma US, Inc. Northbrook, IL 60062, NDC 0469-3211-10
- Lots / codes
Lots: F1700164 Exp. 02/20; A000000220 Exp. 06/20
- Quantity
- 63600 vials
- Company
- Astellas Pharma US Inc, Northbrook, IL
- Distribution
- Nationwide.
- Initiated
- January 22, 2018 · Voluntary: Firm initiated
- Classified
- February 27, 2018
- Reported
- February 14, 2018
- Ended
- May 1, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Micafungin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.